These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 177209)
1. Vincristine (NSC-67574) in the treatment of small-cell anaplastic carcinoma of the lung. Dombernowsky P; Hansen HH; Sorensen PG; Hainau B Cancer Treat Rep; 1976 Mar; 60(3):239-42. PubMed ID: 177209 [TBL] [Abstract][Full Text] [Related]
2. Vindesine in the treatment of small cell anaplastic bronchogenic carcinoma. Osterlind K; Dombernowsky P; Sørensen PG; Hansen HH Cancer Treat Rep; 1981; 65(3-4):245-8. PubMed ID: 6263469 [TBL] [Abstract][Full Text] [Related]
3. 5-FU in the treatment of small cell anaplastic carcinoma of the lung: a phase II trial. Havsteen H; Sörenson S; Rørth M; Dombernowsky P; Hansen HH Cancer Treat Rep; 1981; 65(1-2):123-5. PubMed ID: 6261945 [TBL] [Abstract][Full Text] [Related]
4. [Adriamycin, cyclophosphamide, vincristine and methotrexate combination chemotherapy of small cell lung cancer]. Saito H; Kawatsu H; Saka H; Yamamoto M; Takagi E; Tsunekawa H; Kawachi H; Nagura E; Sakai S; Nishiwaki K Gan To Kagaku Ryoho; 1988 Jun; 15(6):1909-13. PubMed ID: 2838000 [TBL] [Abstract][Full Text] [Related]
5. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung. Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108 [TBL] [Abstract][Full Text] [Related]
6. Combined modality treatment for oat cell carcinoma of the lung: a randomized trial 1,2,3. Alexander M; Glatstein EJ; Gordon DS; Daniels JR Cancer Treat Rep; 1977; 61(1):1-6. PubMed ID: 193642 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995. Lee YC; McCrystal MR; Christmas TI N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564 [TBL] [Abstract][Full Text] [Related]
8. Phase II study of vinblastine in small cell carcinoma of the lung. Sörenson S; Osterlind K; Dombernowsky P; Hansen HH Cancer Treat Rep; 1983 Mar; 67(3):293-5. PubMed ID: 6299548 [TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer. Shepherd FA; Evans WK; MacCormick R; Feld R; Yau JC Cancer Treat Rep; 1987 Oct; 71(10):941-4. PubMed ID: 2820571 [TBL] [Abstract][Full Text] [Related]
10. Etoposide/vincristine-based chemotherapy with or without carboplatin in extensive-stage small cell lung cancer: a prospective randomized phase III trial. Gatzemeier U; Pawel JV; Laumen R; Hossfeld DK; Neuhauss R Semin Oncol; 1994 Jun; 21(3 Suppl 6):31-5. PubMed ID: 8052871 [TBL] [Abstract][Full Text] [Related]
11. cis-Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung. Sierocki JS; Hilaris BS; Hopfan S; Martini N; Barton D; Golbey RB; Wittes RE Cancer Treat Rep; 1979; 63(9-10):1593-7. PubMed ID: 227598 [TBL] [Abstract][Full Text] [Related]
12. Alternating non-cross-resistant drug combinations in the treatment of metastatic small-cell carcinoma of the lung. Krauss S; Lowenbraun S; Bartolucci A; Buchanan R; Birch R Cancer Clin Trials; 1981; 4(2):147-53. PubMed ID: 6265109 [TBL] [Abstract][Full Text] [Related]
13. Phase II study of teniposide in small cell carcinoma of the lung. Pedersen AG; Bork E; Osterlind K; Dombernowsky P; Hansen HH Cancer Treat Rep; 1984 Oct; 68(10):1289-91. PubMed ID: 6098366 [TBL] [Abstract][Full Text] [Related]
14. Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinoma. Jacobs RH; Bitran JD; Deutsch M; Hoffman PC; Sinkule J; Purl S; Golomb HM Cancer Treat Rep; 1987 Mar; 71(3):311-2. PubMed ID: 3028621 [TBL] [Abstract][Full Text] [Related]
15. Upper hemibody and local chest irradiation as consolidation following response to high-dose induction chemotherapy for small cell bronchogenic carcinoma--a pilot study. Mason BA; Richter MP; Catalano RB; Creech RB Cancer Treat Rep; 1982 Aug; 66(8):1609-12. PubMed ID: 6286119 [TBL] [Abstract][Full Text] [Related]
16. [Effects of a combination chemotherapy "VEMA" consisting of vincristine, cyclophosphamide, methotrexate and ACNU in the treatment of small cell bronchogenic carcinoma]. Kojima T; Ito Y; Nakanishi F; Sugihara T; Nagata K; Kamiya O; Ohara K; Hoshino A Gan To Kagaku Ryoho; 1983 Jun; 10(6):1491-6. PubMed ID: 6307169 [TBL] [Abstract][Full Text] [Related]
17. Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer. Leighl NB; Goss GD; Lopez PG; Burkes RL; Dancey JE; Rahim YH; Rudinskas LC; Pouliot JF; Rodgers A; Pond GR; Shepherd FA Lung Cancer; 2006 Jun; 52(3):327-32. PubMed ID: 16597474 [TBL] [Abstract][Full Text] [Related]
18. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy. Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527 [TBL] [Abstract][Full Text] [Related]
19. CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma. Poplin EA; Aisner J; Van Echo DA; Whitacre M; Wiernik PH Cancer Treat Rep; 1982 Jul; 66(7):1557-9. PubMed ID: 6284360 [TBL] [Abstract][Full Text] [Related]
20. [The combination chemotherapy of vincristine, methotrexate, ACNU, and adriamycin for anaplastic carcinoma of the lung]. Meguro S; Kobayashi T; Chinen T; Usui N; Yamazaki H; Kobayashi A; Nagata T; Yokoyama K; Kuraishi Y; Ichiba K; Abe M Gan To Kagaku Ryoho; 1982 Jul; 9(6):1012-8. PubMed ID: 6964043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]